As patients consider drugs like Wegovy, Ozempic, Zepbound and Mounjaro to treat obesity, experts say the choices are not so ...
A new generic of the GLP-1 drug Victoza, which is similar to popular medications like Ozempic, Wegovy, Mounjaro, and Zepbound ...
Signati Medical has completed enrolment in its first-in-human clinical trial for the sealed vasectomy procedure using the ...
The first large, head-to-head comparison between next-generation weight loss drugs finds a clear advantage to one.
And now, medical company Roche has emerged as a significant player ... Shares of Novo Nordisk, the maker of Wegovy, fell by 4 ...
The active ingredient in Eli Lilly's Mounjaro and Zepbound leads to more weight loss than the active ingredient in Novo ...
A surge in demand for popular weight loss injections has led to a shortage, leaving thousands of obesity patients in New ...
We've all seen the ads and read about celebrities who have successfully lost weight using one of the new weight loss ...
Try the Pan Seared Veal Chop. So now it’s not just technology that is under pressure……the weakness that we’ve seen in tech over the past week or so has now moved onto the broader market.
The best stocks below represent the drugmakers with the most interesting weight loss treatments available for sale ... LLY's FDA-approved weight loss drug is Zepbound, known generically as ...
Novo Nordisk, Eli Lilly and Pfizer are developing weight loss pills. Meanwhile, digital health funding shows ‘measured ...